Evidence map›Paper›PMID 38286179›Full record

ArticleKidney international2024

Critical Role of histone deacetylase 3 in the regulation of kidney inflammation and fibrosis.

Yuguo Wang, Baihai Jiao, Zhaoyong Hu, Yanlin Wang

Open access · greenAbstract read
In one paragraph

Article in Kidney international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. The histone deacetylase family in health and disease.Signal transduction and targeted therapy · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. The m5C orchestrator NSUN7 drives SPARC/HMGB1 axis-mediated inflammation to exacerbate kidney injury.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Macrophage RNA polymerase II subunit 5-mediating protein deficiency exacerbates kidney inflammation and fibrosis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. RELA Ablation Contributes to Progression of Hepatocellular Carcinoma with TP53Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yuguo WangSection of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Baihai JiaoDivision of Nephrology, Department of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Zhaoyong HuSection of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Yanlin WangSection of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; Division of Nephrology, Department of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut, USA; Renal Section, VA Connecticut Healthcare System, West Haven, Connecticut, USA. Electronic address: yanlwang@uchc.edu.
Baylor College of Medicine · USUniversity of Connecticut · US

Funding

Cellular and Molecular Mechanisms of Renal FibrosisR01DK095835 · NIDDK · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI WANG, YANLIN · 2012 to 2021
$3.2M
Novel mechanisms of kidney inflammation and fibrosisR01DK134475 · NIDDK · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI YANLIN WANG · 2023 to 2026
$2.1M
BLRD VA I01 BX002650NIDDK NIH HHS R01 DK095835NIDDK NIH HHS R01 DK134475
6 · The paper itself

Abstract

Chronic kidney disease (CKD) is characterized by kidney inflammation and fibrosis. However, the precise mechanisms leading to kidney inflammation and fibrosis are poorly understood. Since histone deacetylase is involved in inflammation and fibrosis in other tissues, we examined the role of histone deacetylase 3 (HDAC3) in the regulation of inflammation and kidney fibrosis. HDAC3 is induced in the kidneys of animal models of CKD but mice with conditional HDAC3 deletion exhibit significantly reduced fibrosis in the kidneys compared with control mice. The expression of proinflammatory and profibrotic genes was significantly increased in the fibrotic kidneys of control mice, which was impaired in mice with HDAC3 deletion. Genetic deletion or pharmacological inhibition of HDAC3 reduced the expression of proinflammatory genes in cultured monocytes/macrophages. Mechanistically, HDAC3 deacetylates Lys122 of NF-κB p65 subunit turning on transcription. RGFP966, a selective HDAC3 inhibitor, reduced fibrosis in cells and in animal models by blocking NF-κB p65 binding to κB-containing DNA sequences. Thus, our study identified HDAC3 as a critical regulator of inflammation and fibrosis of the kidney through deacetylation of NF-κB unlocking its transcriptional activity. Hence, targeting HDAC3 could serve as a novel therapeutic strategy for CKD.

Indexed as

Histone DeacetylasesNephritisRenal Insufficiency, ChronicAnimalsFibrosisHistone Deacetylase 3Histone Deacetylase InhibitorsInflammationKidneyMiceNF-kappa BHistone Deacetylase 3Histone Deacetylase InhibitorsHistone DeacetylasesNF-kappa BdeacetylationfibrosisHDAC3inflammationNF-κB

Identifiers

PMID38286179
PMCPMC12256120
OpenAlexW4391288709

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.